Last $3.50 USD
Change Today -0.06 / -1.69%
Volume 886.9K
PGNX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Israel M.D.

Senior Vice President of Medical Affairs & Clinical Research, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

56$827,330
As of Fiscal Year 2012

Background*

Dr. Robert J. Israel, M.D. serves as a Senior Vice President of Medical Affairs & Clinical Research at Progenics Pharmaceuticals Inc. and served as its Senior Vice President, Medical Affairs since 2002. Dr. Israel has been a Consultant to the Solid Tumor Service at Sloan-Kettering since 1987. He joined Progenics Pharmaceuticals Inc. in October 1994 and served as its Vice President, Medical Affairs. Dr. Israel served as the Director, Clinical Research-Oncology and Immunohematology ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
The University of Pennsylvania
BA
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Salary$397,407
Bonus$83,455
Total Annual Compensation$480,862

Stock Options*

All Other Compensation$15,448
Exercised Options7,000
Exercised Options Value$29,842
Exercisable Options157,833
Unexercisable Options106,667
Total Value of Options$29,842
Total Number of Options271,500

Total Compensation*

Total Annual Cash Compensation$496,310
Total Short Term Compensation$480,862
Other Long Term Compensation$15,448
Total Calculated Compensation$827,330
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $3.50 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
Cell Therapeutics, Inc.
$1.3M
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Aijaz Tobaccowalla Managing Director, Additional Non-Executive Director, Member of Share Transfer Committee, Member of Audit Committee and Member of Shareholders' / Investors' Grievance Committee
Wyeth Limited
--
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
--
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.